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ABSTRACT* 
Objectives: The purpose of this study was to 
conduct a health technology assessment (HTA) of 
automated dose dispensing in the Danish primary 
health care sector. The present article answers the 
sub question of how various groups of actors spoke 
about and understood the shaping of automated 
dose dispensing (positioning in discourses). 
Methods: The project utilized two methods: 11 
qualitative research interviews with selected key 
actors and a net-based qualitative questionnaire of 
97 selected practitioners. 
Results: Three main types of discourse were 
identified with respect to the development of 
automated dose dispensing, namely ‘optimistic’, 
‘sceptical’ and ‘pragmatic’. A wide diversity of 
opinion about automated dose dispensing was 
identified among the three discourses and their 
attendant scenarios. A number of factors are found 
in all three types of discourse, and are therefore 
considered to express common recommendations 
for decision makers and practitioners. These factors 
are described in the article. 
Conclusions: The article argues in favour of HTA, 
which to a great extent clarifies and initiates the 
perspectives of various groups of actors about the 
same technology. Our analyses show that 
conscious strategies must be employed to make the 
technology work successfully with the actors 
involved. The preferences, ideas and proposals for 
future actions and initiatives identified in the project 
could be the basis for defining future development 
strategies. 
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DISPENSACIÓN AUTOMÁTICA DE DOSIS 
EN LA ATENCIÓN PRIMARIA DANESA - 
UNA TECNOLOGÍA EN CONSTRUCCIÓN 
 
RESUMEN 
Objetivos: El propósito de este estudio fue realizar 
una Evaluación de Tecnología Sanitaria (ETS) de la 
dispensación automática de dosis en la atención 
primaria danesa. El presente artículo responde a la 
sub-pregunta de cómo varios grupos de actores 
hablan y entienden la idea de la dispensación 
automática de dosis (posicionamiento en discurso). 
Métodos: El proyecto utilizó dos métodos: 11 
entrevistas de investigación cualitativa con actores 
clave seleccionados y un cuestionario cualitativo en 
97 facultativos seleccionados. 
Resultados: Se identificaron 3 tipos fundamentales 
de discursos respecto a la dispensación automática 
de dosis, el optimista, el escéptico, y el pragmático. 
Se identificó una amplia diversidad de opiniones 
sobre la dispensación automática de dosis entre los 
3 discursos y los consecuentes escenarios. Se 
encontraron varias variables en todos los tipos de 
discurso, y por tanto se consideró expresar 
recomendaciones comunes para los políticos y los 
facultativos. Estos factores se describen en este 
artículo. 
Conclusiones: Este artículo discute a favor de la 
ETS, que clarifica bastante y apunta las 
perspectivas de varios grupos de actores sobre una 
misma tecnología. Nuestro análisis muestra que 
deben emplearse estrategias conscientes para hacer 
que la tecnología funcione suficientemente bien con 
los actores involucrados. Las preferencias, ideas y 
propuestas de futuras acciones e iniciativas 
identificadas en el proyecto pueden ser la base de la 
definición de futuras estrategias a desarrollar. 
 
Palabras clave: Cumplimiento del paciente. 
Automatización. Investigación cualitativa. 
Dinamarca. 
 
 
 
 
INTRODUCTION 
In 2001, legislation was passed requiring Danish 
pharmacists in the primary health care system to 
supply drugs in automated dose packs to 
individuals, automated dose dispensing.1-4 Thus, 
dose dispensing done manually by nurses in the 
eldercare system could now be automated by 
pharmacies and supplied as dose packs of 
medication for two weeks of use at a time. The 
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Danish Medicines Agency has the authority to 
approve ‘dose-pack’ pharmacies, which then have 
permission to install and use special equipment that 
can automatically dispense medication in dose 
packs. In June 2007, a total of 32,656 people in 
Denmark received medication dispensed in 
automated dose packs.5 
The existing literature in the dose dispensing area 
show that a majority of the studies, which have 
either a controlled design or a before-and-after 
design, were conducted in the USA, UK or Canada 
in hospital settings.6-12 This made transferring the 
results of the studies to a Danish primary sector 
setting very difficult. Even though Danish 
pharmacies have been using the technology 
automated dose dispensing for a couple of years, 
the documented experience base is still limited, and 
the technology has not been implemented to the 
extent that the health care authorities had originally 
anticipated. One of the most important Danish 
experiences with dose dispensing is an experiment 
with manual dose dispensing from 1997, which 
showed that users could achieve greater safety and 
security by using dose dispensed medication.13,14 
To date there are no general systematic evaluations 
of the consequences of increased use of medication 
dispensed in automated dose packs, either 
nationally or internationally. 
Health technology assessment 
A health technology assessment (HTA) of the 
Danish automated dose dispensing scheme 
seemed useful for describing the process leading to 
the finished technology and for describing the 
consequences of the technology. A health 
technology assessment in helath care has been 
defined as “technology assessment in health care is 
a multidisciplinary field of policy analysis. It studies 
the medical, social, ethical, and economic 
implications of development, diffusion, and use of 
health technology”.15 The purpose of conducting an 
HTA of automated dose dispensing in this study 
was specifically to document experience with and 
practical application of the technology. In turn, this 
would make it possible to inform decision makers 
about appropriate application and implementation 
strategies with regard to the technology. The 
obstacle to the technology that must be overcome 
so that use can continue to be improved is in focus.  
The HTA consisted of a project in three parts: 1) a 
literature review16; 2) a qualitative study of actors’ 
perspectives comprising a questionnaire survey of 
practical experience with the implementation and 
operation of automated dose dispensing in the 
primary sector and an interview survey of key 
actors’ opinions and perceptions of the activities, 
consequences and prerequisites for automated 
dose dispensing17,18; 3) a register survey of the use 
of automated dose dispensing and its future 
potential.19,20 Thus, the HTA carried out did not 
cover all HTA aspects, and must therefore be 
regarded a partial HTA. For instance, did the HTA 
not sufficiently cover patient-related experiences 
from using automated dose dispensing. An 
additional study, thus, focused on these patients’ 
aspects.21 
Table 1: Selected results from the register study and the literature study influencing the questions posed in the qualitative study 
Selected results from the register study  influencing 
questions posed in the qualitative study 
Selected results from the literature study influencing the questions posed 
in the qualitative study 
Socio-economic position of current ADD-users:  
* Mostly women (2/3) and elderly (70% more than 70 
years old) 
* About 25 % of the ADD-users live in institutions (elderly 
homes etc.)  
* Only few younger, employed persons among the ADD 
users. 
 
Medicine use:  
* Each month, a typical ADD user receive 5 different 
ADD packed medicines  1 medicine not ADD-packed 
Concerning technology: 
* Very few packing errors are observed when using dose dispensing 
systems  
*  Increased safety as an effect of dose dispensing is experience-based 
rather than evidence-based 
* The are a number of discrepancies between the medication 
profile/patient medication record and dose dispensing charts 
* Some users have problems handling the packages 
* Amount of wasted medicine and discarded medicine seems reduced 
due to dose dispensing systems 
* No evidence that dose dispensing increases the overview of drug 
therapy, safety and control with prescriptions 
* No evidence that dose dispensing alone increases compliance and no 
evidence of any health-related effects following from dose dispensing 
* Dose dispensing combined with patient education, drug use review, 
reduction of daily dosages and individual medication strategies increases 
compliance.  
Potential ADD-users:  
* If all GPs prescribed ADD about 29.000 persons would 
recieve ADD-packed medicine.  
* More than 300.000 persons show a ”stabilized” 
medicine use pattern (3 or more medicines).  
* More women and elderly use ADD-packed medicine  
Concerning organisation: 
* Healthcare professionals are satisfied with dose dispensing systems, 
even though working with the systems is time consuming   
* Barriers for implementation are lack of co-operation (the most influential 
barrier),  unclear working and responsibility  
agreements,  insufficient sharing of electronic data and undefined 
economy 
Before-and-after-analysis:  
* Medication consumption unchanged before and after 
implementation of ADD  
* Turnover in pharmacies increases by from ADD (due to 
a special ADD charge). 
Concerning patient: 
* Individuals with a cognitive, mental, psychological or physical 
impairment are potential users 
* It is unclear if dose dispensing increases patient self-management. 
 
Concerning economy: 
* There is a potential for reduced costs, primarily reduced drug costs and 
personal expenses – no long term economic calculations or results, 
though. 
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This article reports the results from the qualitative 
part of the HTA. For selected results from the 
literature study and the register study influencing 
the qualitative study see Table 1.  
The purpose of the qualitative part of the HTA was 
to explore the variation among selected key actors 
involved in the development of automated dose 
dispensing in Denmark in terms of their attitudes 
towards and their perceptions of activities, 
consequences and assumptions related to 
automated dose dispensing. A secondary purpose 
was to make a theoretical analysis that could 
provide an overall view and understanding of the 
significance of the actors’ perspectives on the 
formation of a technology, in this case automated 
dose dispensing. 
The present article answers the research question 
of how various groups of actors spoke about and 
understood the shaping of the Danish automated 
dose dispensing system (positioning in discourses) 
and it describes the content of the discourses and 
their attendant scenarios. 
 
METHODS  
HTA theory 
The entire HTA worked on the basis of a broad 
understanding of technology.22 A broad 
understanding of technology is advocated on both 
the national and international level.23 In Denmark, in 
particular, the concept of technology is often 
considered to have four elements – patient, 
organisation, technology and economy – all equally 
important with respect to carrying out a HTA.23 We 
use this model in this project, which is why all four 
elements are part of the analyses below.22 
An HTA can be conducted at different phases of the 
technology24:  
• Phase 1: Technology not yet developed 
• Phase 2: Technology ahead of introduction 
• Phase 3: Technology being introduced 
• Phase 4: Technology in general use 
• Phase 5: Technology on way out 
 
Automated dose dispensing in Denmark is in phase 
3. In this phase, the social and technical design of 
the technology is being changed and optimised 
continuously, and the final result (phase 4) can 
prove to be very different from the conclusions of an 
evaluation made in phase 3. A future-directed 
technological assessment conducted in phase 3 
follows the process of the technology as it is 
introduced, thus providing the opportunity to help 
optimise the technology.  The weakness of 
conducting a HTA in phase 3, though, is that 
observations must be made on an unstable object.   
Therefore, in keeping with the HTA project’s general 
definition of technology, the study was based on the 
theoretical assumption that technology is not just a 
technique that will be implemented unchanged in 
society after the development phase. Since 
technology is constructed through social practices 
and meanings, it will be constructed differently by 
different social groups depending on their opinions. 
A constructionist approach was needed to 
encompass the fact that technology is ‘narrated’ and 
constructed in different versions, depending on who 
is interpreting. Therefore, a discourse concept25 and 
the social construction of technology theory (SCOT 
theory) were used to conduct our analyses.26 
Discourse analysis can be used in studies of how 
certain ways of speaking about and understanding a 
segment of the world are used to promote and 
influence a case, and which statements can be 
made at a given point in time, in a given situation 
and by whom.27 
One main point of the SCOT theory is that the 
‘construction’ of the actors takes place 
simultaneously along with the construction of a 
technology. In addition to a theoretical approach, 
the SCOT theory also comprises a systematic 
three-part method of analysis for technology 
development: sociological deconstruction, social 
construction and explanation/generalisation.26 For 
details on the SCOT theory see Table 2. 
 
Table 2: Content of the SCOT theory26  
Sociological deconstruction Social construction Explanation/generalisation 
Relevant social groups of a given 
technology and its interpretive 
flexibility are described: 
- a relevant social group has the 
same perception of a technology, 
considers the technology to have 
the same problems, etc. 
- relevant social groups constitute a 
technology by giving it meaning 
- there are as many technologies 
as there are relevant social 
groups 
- the relevant social group’s 
contribution to the total variation 
in opinion about a technology is 
designated the interpretive 
flexibility of the technology. 
 
The concepts of closing and stabilising 
the technology are described: 
- if a controversy over a technology 
is closed, the interpretive 
flexibility disappears, consensus 
is established between the 
various relevant groups, and the 
technology prevails 
- Stabilising refers to the 
development of a technology 
within one relevant social group 
- Stabilisation is not a question of 
either-or, but rather expresses the 
idea that there can be a greater 
or lesser degree of stabilisation 
within each of the relevant social 
groups. 
A broader explanation of technological 
development is developed through the 
concept of a technological framework 
- a technological framework 
structures the interaction 
between actors in a relevant 
social group, but the framework is 
not characteristically tied to an 
individual, system or institution: it 
is localised between the actors 
- content of a technological 
framework may include: goals, 
key problems, solution strategies 
and requirements, theories, tacit 
knowledge, test procedures, 
design methods, design criteria, 
user practice, alternatives, 
exemplary objects and 
expectations 
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Study 
The project design comprises qualitative research 
interviews with key actors, which as such allow in-
depth analyses of the organisational mechanisms in 
connection with the implementation and ongoing 
construction of automated dose dispensing, as well 
as a qualitative questionnaire survey of selected 
practitioners, because they have actual experience 
in implementing the technology available at the time 
of the survey.  
Interviews 
Eleven interviews with key people and 
representatives of the pharmacies, general medical 
practice, hospital doctors, main authorities, 
professional organisations for nurses, doctors and 
pharmacists, the drug industry and patients were 
carried out. The interviewees were recruited from a 
snowball technique, where a literature search gave 
ideas for the first interviewees, who then suggested 
new interviewees. The interviews were arranged by 
e-mail and through the local authority in the home 
care system. The interviews took place between 
November 2003 and August 2004. The interviews 
were conducted using a semi-structured guide 
containing the following general themes: 
• The actual course of events with regard to the 
design and organisational placement of 
automated dose dispensing. 
• Assumptions (facilitators and obstacles). 
• Expectations about the consequences of 
automated dose dispensing, its actual impact 
and subsequent explanations 
• Development options and alternatives  
The individual interview guides were adapted to 
each actor’s place in the system, just as data from 
previous interviews were used to further develop the 
questions. Interviews lasted from 60-90 minutes; all 
interviews were recorded on tape and subsequently 
transcribed in thematic form, after which they were 
sent to the people interviewed for their approval. 
After approval, the thematic transcriptions were 
coded in the analysis program NVivo, and every 
theme in the data material was systematically 
described. 
Qualitative questionnaire survey 
The narrations from practice were collected through 
a qualitative questionnaire survey that aimed to 
gather practical knowledge about local plans and 
experience with the implementation and operation 
of automated dose dispensing. On the advice of the 
drug consultant for each region, a questionnaire 
was sent to representatives (home care, 
pharmacists and GPs) of the one local authority in 
each region considered to have the most 
experience with automated dose dispensing. The 
questionnaire was also sent to the regional drug 
consultants and all 10 ‘dose-pack’ pharmacies in 
Denmark. In total, questionnaires were sent to one 
selected local authority in each of Denmark’s 
thirteen regions, as well as to selected areas in the 
City of Copenhagen and Frederiksberg. One local 
authority was excluded due to limited use of 
automated dose dispensing. The questionnaire 
consisted of open responses exclusively and asked 
broadly about experiences with the start-up and 
operation of automated dose dispensing, as well as 
what respondents would like to see happen with 
automated dose dispensing in future. In total, 
questionnaires were sent to 97 representatives of 
which 47 responded: 24 from the home care 
services (out of 47 possible), 7 general practitioners 
(out of 15 possible), 7 from the pharmacies that 
distribute dose packs (out of 15 possible), 5 from 
pharmacies that pack the doses (out of 10 
possible), as well as 4 from regional level (out of 15 
possible).  
Data analyses 
Kvale uses the following interpretation levels for 
qualitative analyses28: 
• The self-understanding of those being 
interviewed 
• Critical common sense interpretation 
• Theoretical interpretation 
Related to these levels, a theme analyses was 
conducted of interview data using a very descriptive 
categorisation. This was done in order to account 
for the variation of opinions found in the material 
close to the self-understanding of those being 
interviewed. The categorisations were inspired by 
the HTA reference frame mentioned above23, and 
can thus be said to form the basis for a critical 
common sense interpretation level. 
The written responses from qualitative 
questionnaire survey were collected and retold as 
one story describing experiences with start-up, 
organising the scheme, including work flow, staff, 
cooperation, users of the scheme and the 
advantages and disadvantages experienced with it. 
Then a list of ‘good solutions’ and ‘recurring 
problems and wishes for the future’ was compiled. 
The stories from the ‘dose-pack’ pharmacies were 
collected into one single story in the same way.   
In the present theoretical analyses, an interpretation 
based on the data categorisations from the theme 
analyses conducted in accordance with the 
discourse concept and SCOT theory is presented. 
Using the discourse analysis as an analytical point 
of departure with respect to the qualitative data 
material the motives and barriers of the actors with 
regard to automated dose dispensing was shown. 
As the first step in the discourse analysis, a set of 
profiles for the actors who took part in the interview 
survey was developed and comprises the following 
main technological framework elements from the 
SCOT theory: 
1. Understanding and delimitation of the 
technology 
2. Main objectives and expectations 
3. Understanding key problems 
4. Understanding key solutions 
These actor profiles, along with the theme analyses 
of the interview survey and results of the 
questionnaire survey, were then used as the basis 
for the following more general and interdisciplinary 
construction of the discourses the actors conducted 
about the implementation and use of automated 
dose dispensing.  
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The first two of the SCOT categories listed above 
were systematically reviewed (understanding and 
delimitation of the technology and main objectives 
and expectations) for each of the identified main 
discourses and each of the HTA themes: 
technology, organisation, patient and economy. We 
also evaluated the extent to which there were 
tendencies to close and stabilise the understanding 
of the technology. In conclusion, we wrote a 
scenario concerning the main challenges, problems 
and solutions for each discourse based on all of the 
analyses. 
 
RESULTS  
Actor profiles and main discourses 
Three main types of discourse with respect to 
automated dose dispensing in Denmark were 
identified, namely: ‘optimistic’, ‘sceptical’ and 
‘pragmatic’ discourses. 
The ‘optimistic’ discourse exists among enthusiastic 
supporters and innovators in the automated dose 
dispensing scheme, actors who have great 
expectations for and interest in the potential of the 
technology. Actors who dominate in this discourse 
are representatives of pharmacies and local 
authorities, as well as regional drug consultants, 
users and practitioners. 
The ‘sceptical’ discourse exists primarily among 
actors who see problems with the scheme and do 
not believe in the expectations about the technology 
that have been  promoted by optimists in particular, 
as well as actors whose interests are threatened by 
the introduction of the scheme. Actors who 
dominate in this discourse are representatives of 
doctors and nurses, practitioners in these 
professional groups as well as scientists who lack 
documentation and evidence about the 
consequences and potential of the scheme. 
The ‘pragmatic’ discourse exists among the 
solution-oriented actors who believe that automated 
dose dispensing is valuable if the technology is 
used correctly, regardless of any weaknesses in the 
scheme. Thus, they are to a certain extent willing to 
adapt their expectations to the technology and the 
related system in order to optimise the scheme. 
Dominant actors are representatives of the central 
administration (Ministry of the Interior and Health, 
The Danish Medicines Agency and the National 
Board of Health).  
A technical discourse exists as a sub-group under 
the pragmatic discourse, conducted by technicians 
who design and implement the many technical, 
organisational and economic systems that make up 
the automated dose dispensing scheme. Dominant 
actors include The Danish Medicines Agency, The 
Danish Pharmaceutical Association, pharmacies 
packing the doses, the pharmaceutical industry, 
local authority and regional actors and others with 
special insight into the systems in question.  
Main challenges and solutions 
Each of the general types of discourse is 
documented with regard to the HTA themes 
technology, organisation, patient and economy. 
Three scenarios that correspondent to the general 
discourses identified are used to summarise the 
theoretical analysis. The aim here is to show the 
connection and logic in each of the main discourses 
in order to analyse their possible contribution to 
further development. 
In the ‘optimistic’ scenario, automated dose 
dispensing is considered a medical technology with 
the potential to become a key technology for drug 
safety and rational pharmacotherapy. The scheme 
is evaluated as the tool to ensure that ‘the right 
person gets the right medicine at the right time and 
at the – presumably – right price’. automated dose 
dispensing will achieve better compliance, patient 
satisfaction and fewer hospitalisations if 
administered properly. The scheme also has the 
potential to lead to considerable rationalisation for 
home care, which can mean more relevant use of 
home care resources and direct savings. 
According to the ‘optimistic’ discourse, the 
challenge in future will be to expand the technology, 
so that its full potential is realised. This will require 
numerous proposals for offensive solution strategies 
aimed at overcoming technical, organisational and 
economic obstacles (see Table 3).  
In addition to the proposed solutions mentioned in 
Table 3, some doctors and pharmacists point out 
that the economic benefits are not strong enough to 
strengthen expansion of the scheme. Some actors 
in the pharmacy sector see opportunities in this 
discourse for solving organisational problems 
connected with expansion through greater utilisation 
of the pharmacy’s professional clinical pharmacy 
resources. This could be done, for example, by 
paying pharmacies for doing medication reviews, 
patient counselling and follow-up.  
Conversely, increased expenses are not a desired 
solution at the local authority level, where actors in 
the optimistic scenario also want the scheme 
expanded. Some actors see potential in making 
automated dose dispensing obligatory for some 
patient groups, since it is expected that the savings 
potential of the scheme will be realised due to the 
increased number of people included under the 
scheme.  
In the ‘sceptical’ scenario, automated dose 
dispensing is considered a new health technology 
that can produce new errors posing greater patient 
safety risks. The scheme is also seen as a 
centralised, organisational solution that is 
economically motivated. In this scenario, automated 
dose dispensing is a system for automatic medicine 
dispensing without sufficient assurance that 
documentation (dosage charts, etc.) is updated and 
correct; that prescribing is in order generally; that 
prescription changes are implemented correctly; 
that other medications are given correctly; that 
patients who take their own medications are 
informed and in control of the situation; that 
treatment results are monitored adequately and that 
patients are observed. In accordance with this 
discourse, it is not clear who is actually responsible 
for ensuring that these tasks are carried out, and 
this more than any other factor is seen as the main 
weakness of the scheme.  
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While patients may indicate satisfaction with the 
scheme, sceptics say that patients can also 
experience pressure to accept the scheme, or that 
they feel insecure, for example, by discovering 
errors or from lack of contact with competent 
professionals. Actors in this discourse question 
whether the medication of the weakest patients is 
stable enough for them to use the scheme, 
particularly when hospitalised and when their 
prescriptions are changed. Sceptics fear that big 
savings in home care increase costs from drug 
related problems. They also fear that the scheme 
will lead to cuts in home care or increase the tasks 
of caregivers without compensation. 
For this discourse, the future challenge is safety and 
clarifying responsibility. First and foremost are the 
tasks of clarifying responsibility, economy, problems 
with patient safety and what conditions need to be 
in place so that automated dose dispensing can 
lead to more realistic goals. 
The ‘sceptical’ discourse gives rise to several 
proposals for defensive solution strategies (see 
Table 3). Just as in the ‘optimistic’ scenario, these 
proposals are targeted at the constructive removal 
of technical, organisational and economic obstacles. 
In the ‘pragmatic’ scenario, automated dose 
dispensing is seen as a good service that should be 
offered to people in a modern health care sector. 
Used correctly, the technology has the potential to 
strengthen safety in administering medications, 
particularly in residential care for the elderly.  
The main challenge for actors in the pragmatic 
scenario is to achieve acceptance of automated 
dose dispensing. Particularly for practitioners, this 
will mean that the scheme must find its place 
among other methods of administering medication; 
finding compromises so that the technology can 
work for all involved parties, which can sometimes 
have conflicting interests; and most importantly 
avoiding fiascos. To achieve these ends, it is 
paramount to ensure an acceptable level with 
regard to expanding the scheme; to secure the main 
qualities concerning administering the medication to 
weak patients; to avoid heavy pressure to cut costs; 
and to overcome resistance among practitioners 
and professional organisations. 
The pragmatic agenda leads to more dialogue and 
learning-oriented solution strategies than those in 
the other two discourses (see Table 3). As a starting 
point, technical changes to the scheme are not 
considered necessary; focus is on the 
organisational dimension instead. The actors in this 
discourse are not prepared to initiate large studies 
or large reforms of automated dose dispensing. 
They see ‘puzzle-solving’ as the way forward.   
 
DISCUSSION 
The above qualitative analyses identified a 
significant variation in opinion (high interpretative 
flexibility) among the actors involved in 
implementing the automated dose dispensing 
scheme. However, at the same time a number of 
Table 3: Problem-solving proposals from the three discourses in the ADD area 
Proposals from the ‘optimistic’ 
discourse 
Proposals from the ‘sceptical’ 
discourse 
Proposals from the ‘pragmatic’ 
discourse 
* A medication review should be 
conducted to ensure there are no 
drug-related problems before the 
patient joins the scheme  
* A dosage chart should include all of 
the patient’s medications (dose-
dispensed and not dose-dispensed) 
* The pharmacy should update the 
dosage chart for non-ADD 
medications as well as ADD 
medications 
* Instructions should be drawn up for 
hospitals on how to handle patients 
receiving ADD medications upon 
hospitalisation or discharge 
* The patient should have the correct 
ADD medicine from the moment of 
prescribing, for example, by having 
the hospital supply dosage 
dispensed medication until the 
pharmacy is able to supply ADD 
medication to the patient  
* The pharmacies should be obligated 
by law or volunteer to supply new 
ADD medication for less than a week 
when acute changes in medication 
have been made 
* Home caregivers should take 
responsibility for removing 
medication from dose packs when a 
prescription is discontinued or 
reduced  
* Safety problems and new errors 
should be charted 
* Research should be conducted to 
document impact on safety, 
compliance, health, hospitalisation 
and patient experience 
* Executive orders and guidelines on 
ADD should be adapted in order to 
avoid safety problems, particularly 
with regard to hospitalisation and 
discharge  
* Guidelines should be drawn up 
regarding responsibility for processes 
concerning administration of dosage 
charts, initiating prescription refills, 
changes in dose packs delivered, 
patient information, follow-up and 
observation 
* Common, real-time electronic 
documentation systems should be 
established 
* Unrealistic expectations about 
savings should be dropped; e.g. 
home care observations should be 
maintained when considered 
necessary and there should be 
payment for medication reviews 
* Formal responsibility should remain 
where it is (with the patient’s doctor) 
* Guidelines should be drawn up for 
the continuation of care 
* Instructions should be drawn up 
when needed 
*  Participants should be forward 
looking and solution oriented, 
bringing the involved parties 
together, rather than focusing on 
obstacles and conflicts of interest 
*  Frequently asked question (FAQ) 
services should be set up 
* The best solutions should be 
developed on the local level by 
exchanging experience (via contact 
person schemes at pharmacies, in 
local authorities and home care 
service) 
* The scheme should be limited to 
simply being a new way of 
packaging medication and thereby 
avoid the idea that all present quality 
aspects of the medication process 
must be solved as part of the ADD 
scheme 
* Safety problems should be solved by 
ensuring that the scheme is only 
used for relevant target groups 
* Work in the home care service 
should be redistributed and no more 
than minor savings should be 
expected 
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solutions were developed in the practice field, 
showing that the scheme can be adapted and made 
to work. The lack of agreement and common 
understanding can be seen as a weakness in the 
scheme. In contrast, however, the diversity of 
perspective and perception can be regarded as 
resources that can be used to develop and 
strengthen the chance for organisational solutions 
to work successfully in many different cultural, 
social and technical contexts. 
This study will be most useful seen from this 
constructive point of view. Acknowledging the logic 
of the views of the various actors will open up many 
alternative options for action. Similarly, the solutions 
posed by the scenarios above all have relevant 
development potential. 
It is not possible to make objective 
recommendations on the basis of a study of actors’ 
perspectives. If automated dose dispensing is to 
result in better use of medication, we recommend 
first and foremost that the discourses meet so that 
the participants in them have the opportunity to 
listen to the agendas of the other discourses and 
see their own contribution as part of the overall 
system, as well as to evaluate the effect of these 
different contributions and understandings. We 
agree with ten Have29 and Reuzel30, both of whom 
claim that an HTA in which the (often conflicting) 
interests of the various actors are put into play 
results in a richer and more interesting HTA than 
the ‘traditional’ one-sided focus on safety, 
effectiveness and cost-effectiveness. Generally, we 
support the international literature31-33 according to 
which new technologies should be evaluated before 
they are allowed to diffuse, unevaluated, into clinical 
practice. But when such an HTA is not conducted 
prior to the introduction of the technology, an HTA in 
the late phases of the technology must be 
considered preferable to no assessment 
whatsoever. 
Several factors appear in all three types of 
discourse, and they are thereby evaluated as 
expressing common recommendations for decision 
makers and practitioners, as follows:  
• Ensure that guidelines are drawn up for the 
continuation of care 
• Ensure that instruction are drawn up as 
needed to clarify the division of responsibility  
• Find the best solutions at local level by 
exchanging experience 
• Chart safety problems and new types of 
error 
• Ensure that automated dose dispensing is 
only used for relevant target groups 
• Make delivery times for acute changes in 
medication more flexible 
• Improve the quality of documentation 
systems so that all actors have correct, 
current and updated information at all times 
As mentioned earlier, it has not been possible to 
identify other studies using the same social 
constructionist approach as this study to show the 
significance of various actors’ viewpoints on the 
design of automated dose dispensing. Nonetheless, 
the automated dose dispensing literature provides 
the opportunity to discuss the extent to which 
selected elements of the three discourses and 
scenarios can be found outside the context of the 
Danish primary health sector. In the following, we 
will compare the three scenarios one by one to 
existing literature.   
The assumption of the optimistic scenario about the 
potential of the scheme as a key technology for 
medication safety is supported in three studies 
documenting that the error rate with automated 
dose dispensing is less than in manually packaged 
dose medication.34-36 Another main expectation of 
the optimistic scenario, that dose dispensing will 
reduce medication expenses, can also be verified in 
the literature.13,33,37-40 
In the ‘sceptical’ scenario, particular problems lie in 
clarifying where responsibility lies and the fear of 
cutbacks in home care with a subsequent increase 
in drug related problems among patients. The 
literature also shows that lack of clarification about 
the division of labour and responsibility concerning 
the tasks related to dose dispensing has presented 
obstacles to the successful implementation of the 
technology.14,39,41-43 Implementation of the dose-
dispensing scheme has met particular resistance 
from nurses39,42,43 and doctors.44,45 That automated 
dose dispensing alone will lead to increased 
compliance in individual patients cannot be 
documented on the basis of the available literature, 
which, on the contrary, emphasises the necessity of 
combining automated dose dispensing with other 
initiatives, such as reducing daily doses, patient 
education, medication reviews, etc. in order to 
achieve greater compliance.12,46-48 
As mentioned earlier, the key challenge for actors 
included in the pragmatic scenario is acceptance. In 
general, other studies in the field show satisfaction 
with automated dose dispensing and acceptance of 
the technology as a link in the medication process 
among both health care professionals14,35,38,39,41,42,48 
and patients.14,35,45,48-50 
The literature thus provides a basis for ‘verifying’ all 
three discourses/scenarios. However, the 
constructionist approach underlying this study by no 
means attempts to describe the technology 
‘objectively’, but rather to clarify the diversity of the 
given technology.   
Limitations 
The three types of discourse identified in this study 
should first be understood as basic categories 
delineated rather sharply. Many individuals would 
presumably say that they contribute to several 
discourses, and would be unable to identify 
themselves as exclusively ‘optimistic’, ‘sceptical’ or 
‘pragmatic’. These very general discourses are 
carried on by specific groups of actors, but are 
interdisciplinary in terms of objective interest 
groups, called relevant social groups in SCOT 
terminology. Here a relevant social group should be 
understood as ‘forces’ in a social system or as 
gradients that want influence on how a technology 
is designed, for example, in terms of how the 
technology is put into a discourse, rather than as 
cohesive groups. 
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The categorisation of the discourses should be 
understood in this sense. Thus, the groups we have 
proposed are not hard and fast entities, but rather 
comprise the most meaningful interpretations we 
could establish to encompass the empirical 
material. Naturally, the discourses must be seen in 
interplay with other social powers in this context 
involving professions, tasks and interests, for 
example.  
Stabilising the perception of a technology is not 
necessarily a goal in itself. Conversely, it is known 
that conflicts of interest can present serious 
obstacles to achieving the goals expected. Knowing 
the rationale behind other views and interests can 
help develop solutions. We agree with Kazanjian51 
who operates with the concept of ‘strategic HTA’, 
which involves an open discussion of health care in 
a way that highlights societal and political 
implications, through analysis of the influence of 
dominant social relations of technological 
development and diffusion. The present analysis 
can make a contribution to such a strategic HTA. 
See Nørgaard and Morgall52 for another example of 
a HTA with focus on the various perceptions of the 
same technology by different groups of actors. 
The above analysis attempts to remain neutral in its 
presentation of diverse descriptions of the 
technology with respect for the views of the 
informants. As researchers, however, we are also 
‘voices’ in the discourse system and it is not 
possible to observe without interacting with the field. 
In the social-constructionist view53, this co-
construction has a point and the resulting diversity 
of perspectives and opinions is seen as helping to 
develop and strengthen the chances for 
organisational solutions to succeed and function in 
many different cultural, social and technical settings. 
 
CONCLUSIONS 
There are many variations of opinion (high 
interpretive flexibility) about automated dose 
dispensing. ‘Optimistic’, ‘sceptical’ and ‘pragmatic’ 
scenarios can be identified. The analyses carried 
out show that conscious strategies need to be 
drawn up so that the technology can function 
successfully with the involved actors. The 
preferences, ideas and proposals for future actions 
and initiatives identified in the project can be the 
starting point for efforts to define future 
development strategies. The general impression 
from the analysis is that automated dose dispensing 
in the primary health sector is a technology with 
good, potential opportunities to improve the 
medication of weak patients in particular, but that 
there are risks involved and many organisational 
obstacles.  
The article argues for the use of HTA and 
constructivist theory to clarify and set into play the 
perspectives of the various groups of actors about 
the same technology. 
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